Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

Renal Impairment Study of PF-06700841Completed
NCT04260464Phase 1Updated Jan 22, 2024
Sponsor: Pfizer
Healthy Volunteer · Renal Impairment
United States
Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of AgeCompleted
NCT04642079Phase 3Updated Jan 22, 2024
Sponsor: Pfizer
Pneumococcal Disease
United States
Real-World Outcomes of US Talazoparib-Treated Patients With Locally Advanced or Metastatic Breast CancerCompleted
NCT04987931N/AUpdated Jan 22, 2024
Sponsor: Pfizer
Breast Cancer
United States
Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in ChildrenCompleted
NCT00840801Phase 3Updated Jan 19, 2024
Sponsor: Pfizer
Encephalitis, Tick-Borne
Austria, Czechia
A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML PatientsCompleted
NCT02367456Phase 1Updated Jan 19, 2024
Sponsor: Pfizer
Myelodysplastic Syndrome · Acute Myeloid Leukemia · Chronic Myelomonocytic Leukemia
United States, Belgium, Canada, France, Germany +1 more
A Study to Understand the Effects of Carbamazepine on How Vepdegestrant is Processed in Healthy ParticipantsCompleted
NCT06005688Phase 1Updated Jan 16, 2024
Sponsor: Pfizer
Healthy Participants
Belgium
B0151005 Open-Label Extension StudyCompleted
NCT01345318Phase 2Updated Jan 12, 2024
Sponsor: Pfizer
Crohn's Disease
United States, Australia, Belgium, Brazil, Canada +11 more
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and AnorexiaCompleted
NCT04803305Phase 1Updated Jan 12, 2024
Sponsor: Pfizer
Non-small Cell Lung Cancer · Pancreatic Cancer · Colorectal Cancer · Prostate Cancer
United States, Canada
Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial FibrillationCompleted
NCT05321810N/AUpdated Jan 11, 2024
Sponsor: Pfizer
Non-valvular Atrial Fibrillation
Japan
Caffeine Reduction and Overactive Bladder SymptomsTerminated
NCT00754260NAUpdated Jan 11, 2024
Sponsor: University of New Mexico
Overactive Bladder
United States
Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting.Completed
NCT04460911N/AUpdated Jan 11, 2024
Sponsor: Pfizer
Breast Cancer
United States
Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian CancerCompleted
NCT02915523Phase 1, Phase 2Updated Jan 10, 2024
Sponsor: Syndax Pharmaceuticals
Epithelial Ovarian Cancer · Peritoneal Cancer · Fallopian Tube Cancer
United States
Clostridium Difficile Vaccine 2-Dose Versus 3-Dose StudyCompleted
NCT03918629Phase 3Updated Jan 10, 2024
Sponsor: Pfizer
Clostridium Difficile Associated Disease
United States
A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene MutationTerminated
NCT03439514Phase 3Updated Jan 9, 2024
Sponsor: Pfizer
Dilated Cardiomyopathy · Lamin A/C Gene Mutation
United States, Argentina, Belgium, Canada, Italy +5 more
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy InfantsCompleted
NCT04546425Phase 3Updated Jan 8, 2024
Sponsor: Pfizer
Pneumococcal Disease
Australia, Belgium, Czechia, Denmark, Estonia +7 more
Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline TreatmentCompleted
NCT01072539N/AUpdated Dec 29, 2023
Sponsor: Pfizer
Complicated Skin and Skin Structure Infections · Complicated Intra-abdominal Infections · Community-Acquired Bacterial Pneumonia
South Korea
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal WomenCompleted
NCT00406640Phase 3Updated Dec 28, 2023
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Depression · Depressive Disorder · Depressive Disorder, Major
United States, Argentina, Chile, Colombia, Mexico +1 more
Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.Completed
NCT04483505Phase 1Updated Dec 28, 2023
Sponsor: Fundacion CRIS de Investigación para Vencer el Cáncer
Breast Cancer Metastatic · Hormone Receptor Positive Malignant Neoplasm of Breast
Spain
A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic SclerosisTerminated
NCT04915950Phase 2Updated Dec 22, 2023
Sponsor: Pfizer
Raynaud's Phenomenon Secondary to Systemic Sclerosis
United States, United Kingdom
Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal CancerCompleted
NCT02928224Phase 3Updated Dec 21, 2023
Sponsor: Pfizer
BRAF V600E-mutant Metastatic Colorectal Cancer
United States, Argentina, Australia, Austria, Belgium +22 more
PD 0332991 and Cetuximab in Patients With Incurable SCCHNCompleted
NCT02101034Phase 1, Phase 2Updated Dec 21, 2023
Sponsor: Washington University School of Medicine
Carcinoma, Squamous Cell of Head and Neck
United States
A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast CancerCompleted
NCT05584644N/AUpdated Dec 19, 2023
Sponsor: Pfizer
Breast Cancer · Breast Carcinoma · Breast Neoplasms · Breast Tumors
India
Evaluation of a Mobile App to Promote Social Support for Oncology PatientsCompleted
NCT04331678NAUpdated Dec 18, 2023
Sponsor: West Cancer Center
Chemotherapy Effect
United States
Survival Prolongation by Rationale Innovative GenomicsTerminated
NCT03386929Phase 1, Phase 2Updated Dec 18, 2023
Sponsor: Worldwide Innovative Network Association
Non-small Cell Lung Cancer Metastatic · Non-small Cell Lung Cancer Stage IIIB
United States, Israel, Luxembourg, Spain
Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMMLCompleted
NCT04842604Phase 3Updated Dec 18, 2023
Sponsor: Pfizer
Acute Myeloid Leukemia · Myelodysplastic Syndrome · Chronic Myelomonocytic Leukemia
Austria, Canada, Czechia, France, Hungary +6 more

Previous page Next page